|
|
OVERVIEW
|
|
.
|
Chan
TY, Partin AW, Walsh PC, Epstein JI.
Prognostic
significance of Gleason score 3+4 versus Gleason score 4+3 tumor
at radical prostatectomy.
Urology.
2000 Nov 1;56(5):823-7.
Source
|
Abstract
|
Full
text |
Similar
articles
|
|
|
.
|
Kane
CJ, Eggener SE, Shindel AW, Andriole GL.
Variability
in Outcomes for Patients with Intermediate-risk Prostate Cancer
(Gleason Score 7, International Society of Urological Pathology
Gleason Group 2-3) and Implications for Risk Stratification: A
Systematic Review.
Eur
Urol Focus. 2017 Mar 12. pii: S2405-4569(16)30157-2. doi:
10.1016/j.euf.2016.10.010. [Epub ahead of print]
Source
|
Full
text |
Similar
articles
|
|
|
DEFINITION
SUITABLE FOR ACTIVE SURVEILLANCE
|
|
.
|
Loeb S, Folkvaljon Y, Bratt O, Robinson D, Stattin P.
Defining
Intermediate-Risk Prostate Cancer Suitable for Active
Surveillance.
J Urol. 2018 Sep 18. pii:
S0022-5347(18)43908-0. doi: 10.1016/j.juro.2018.09.042. [Epub
ahead of print]
Source
|
Abstract
|
Similar
articles
|
|
|
CLINICAL
STAGE T2C PROSTATE CANCER
|
|
.
|
Klaassen
Z, Singh AA, Howard LE, Feng Z, Trock B, Terris MK, Aronson WJ,
Cooperberg MR, Amling CL, Kane CJ, Partin A, Han M, Freedland SJ.
Is
clinical stage T2c prostate cancer an intermediate- or high-risk
disease?
Cancer.
2015 May 1;121(9):1414-21. doi: 10.1002/cncr.29147. Epub 2014 Dec
9.
Source
|
Full
text |
Similar
articles |
Meeting
abstract
(2015
May 17) | Meeting
abstract
(2014
Feb) | Meeting
abstract
(2012
Feb)
|
|
|
mpMRI
FOR RISK STRATIFICATION
|
|
.
|
Bastian-Jordan M.
Magnetic resonance imaging of the
prostate and targeted biopsy, Comparison of PIRADS and Gleason
grading.
J Med Imaging Radiat Oncol. 2017 Oct 9. doi:
10.1111/1754-9485.12678. [Epub ahead of print]
Source
| Full
text |
Similar
articles
|
|
|
.
|
Emberton
M.
An
end to the phenomenon of 'upgrading' in early prostate cancer?
BJU
Int. 2017 Apr;119(4):506-507. doi: 10.1111/bju.13671. Epub 2017
Mar 20.
Comment
on: Pessoa RR et al, Value of 3-Tesla multiparametric magnetic
resonance imaging and targeted biopsy for improved risk
stratification in patients considered for active
surveillance.
Source
|
Full
text |
Similar
articles
|
|
|
.
|
Pessoa
RR, Viana PC, Mattedi RL, Guglielmetti GB, Cordeiro MD, Coelho RF,
Nahas WC, Srougi M.
Value
of 3-Tesla multiparametric magnetic resonance imaging and targeted
biopsy for improved risk stratification in patients considered for
active surveillance.
BJU
Int. 2017 Apr;119(4):535-542. doi: 10.1111/bju.13624. Epub 2016
Sep 3.
Source
|
Full
text |
Similar
articles
|
|
|
.
|
Reisæter LAR, Fütterer JJ, Losnegård A, Nygård
Y, Monssen J, Gravdal K, Halvorsen OJ, Akslen LA, Biermann M,
Haukaas S, Rørvik J, Beisland C.
Optimising
preoperative risk stratification tools for prostate cancer using
mpMRI.
Eur Radiol. 2017 Oct 6. doi:
10.1007/s00330-017-5031-5. [Epub ahead of print]
Source
| Full
text |
Similar
articles
|
|
|
‘EQUIVOCAL'
PI-RADS LESIONS
|
|
.
|
Sheridan AD, Nath SK, Syed JS, Aneja S, Sprenkle PC, Weinreb JC,
Spektor M.
Risk of Clinically Significant Prostate Cancer
Associated With Prostate Imaging Reporting and Data System
Category 3 (Equivocal) Lesions Identified on Multiparametric
Prostate MRI.
AJR Am J Roentgenol. 2017 Nov 7:1-11. doi:
10.2214/AJR.17.18516. [Epub ahead of print]
Source
| Full
text |
Similar
articles
|
|
|
.
|
Ullrich T, Quentin M, Arsov C, Schmaltz AK, Tschischka A, Laqua N,
Hiester A, Blondin D, Rabenalt R, Albers P, Antoch G, Schimmöller
L.
Risk stratification of 'equivocal' PI-RADS lesions in
mp-MRI of the prostate.
J Urol. 2017 Sep 20. pii:
S0022-5347(17)77559-3. doi: 10.1016/j.juro.2017.09.074. [Epub
ahead of print]
Source
| Full
text |
Similar
articles
|
|
|
PRE-
AND POST-OPERATIVE GLEASON SCORES
|
|
.
|
Henderickx
MMEL, Brits T, Muilwijk T, Adams T, Vandeursen H.
Localized
prostate cancer and robot-assisted laparoscopic radical
prostatectomy: a retrospective, comparative study between pre- and
post-operative Gleason scores.
Acta
Chir Belg. 2017 Jul 18:1-6. doi: 10.1080/00015458.2017.1353234.
[Epub ahead of print]
Source
|
Full
text |
Similar
articles
|
|
|
.
|
Porcaro AB, Siracusano S, de Luyk N, Corsi P, Sebben M, Tafuri A,
Mattevi D, Bizzotto L, Tamanini I, Cerruto MA, Martignoni G,
Brunelli M, Artibani W.
Low-Risk Prostate Cancer and
Tumor Upgrading in the Surgical Specimen: Analysis of Clinical
Factors Predicting Tumor Upgrading in a Contemporary Series of
Patients Who were Evaluated According to the Modified Gleason
Score Grading System.
Curr Urol. 2017 Aug;10(3):118-125.
doi: 10.1159/000447164. Epub 2017 Jul 30.
Source
| Full
text | Similar
articles
|
|
|
PRESENCE
OF EXTRAPROSTATIC EXTENSION
|
|
.
|
Pugh
TJ, Frank SJ, Achim M, Kuban DA, Lee AK, Hoffman KE, McGuire SE,
Swanson DA, Kudchadker R, Davis JW.
Endorectal
magnetic resonance imaging for predicting pathologic T3 disease in
Gleason score 7 prostate cancer: implications for prostate
brachytherapy.
Brachytherapy.
2013 May-Jun;12(3):204-9. doi: 10.1016/j.brachy.2011.12.013. Epub
2012 Jun 5.
Source
|
Full
text |
Similar
articles
|
|
|
.
|
Wallner
KE.
Commentary
on "Endorectal
magnetic resonance imaging for predicting pathologic T3 disease in
Gleason score 7 prostate cancer: Implications for prostate
brachytherapy".
Brachytherapy.
2013
May-Jun;12(3):202. doi: 10.1016/j.brachy.2013.01.001. Epub 2013
Feb 14.
Source
|
Full
text |
Similar
articles
|
|
|
RISK
FACTORS IN THE STRATIFICATION OF PATIENTS WITH INTERMEDIATE-RISK
PCA
|
|
|
|
PROSTATE
VOLUME AND/OR PSA DENSITY
|
|
.
|
Kang
HW, Jung HD, Lee JY, Kwon JK, Jeh SU, Cho KS, Ham WS, Choi YD.
Prostate-specific
antigen density predicts favorable pathology and biochemical
recurrence in patients with intermediate-risk prostate cancer.
Asian
J Androl. 2016 May-Jun;18(3):480-4. doi: 10.4103/1008-682X.154313.
Epub 2015 Jul 7.
Source
|
Full
text |
Similar
articles
|
|
|
.
|
Moschini
M, Gandaglia G, Suardi N, Fossati N, Cucchiara V, Damiano R,
Cantiello F, Shariat SF, Montorsi F, Briganti A.
Importance
of prostate volume in the stratification of patients with
intermediate-risk prostate cancer.
Int
J Urol. 2015 Jun;22(6):555-61. doi: 10.1111/iju.12748. Epub 2015
Mar 17.
Source
|
Full
text |
Similar
articles
|
|
|
.
|
Yashi
M.
Editorial
Comment to: Importance
of prostate volume in the stratification of patients with
intermediate-risk prostate cancer.
Int
J Urol. 2015 Jun;22(6):561-2. doi: 10.1111/iju.12764. Epub 2015
Mar 18.
Source
|
Full
text |
Similar
articles
|
|
|
.
|
Narita
S, Mitsuzuka K, Tsuchiya N, KFull textoie T, Kawamura S, Ohyama C,
Tochigi T, Yamaguchi T, Arai Y, Habuchi T; Michinoku Japan
Urological Cancer Study Group.
Reassessment
of the risk factors for biochemical recurrence in D'Amico
intermediate-risk prostate cancer treated using radical
prostatectomy.
Int
J Urol. 2015 Nov;22(11):1029-35. doi: 10.1111/iju.12898. Epub 2015
Aug 20.
Source
|
Full
text |
Similar
articles
|
|
|
.
|
Mearini
L.
Editorial
Comment to Reassessment
of the risk factors for biochemical recurrence in D'Amico
intermediate-risk prostate cancer treated using radical
prostatectomy.
Int
J Urol. 2015 Nov;22(11):1035-6. doi: 10.1111/iju.12904. Epub 2015
Aug 25.
Source
|
Full
text |
Similar
articles
|
|
|
|
|
|
|
